The efficacy of the Dietary Approaches to Stop Hypertension diet with respect to improving pregnancy outcomes in women with hypertensive disorders.

Abstract

The DASH (Dietary Approaches to Stop Hypertension) diet serves as a dietary pattern for the prevention and control of hypertension. The present study aimed to investigate whether the DASH diet can improve the outcomes of pregnancy with gestational hypertension (GH) and chronic hypertension. The current randomised controlled clinical trial was performed in 85 pregnant women diagnosed with GH and chronic hypertension between July 2015 and December 2017. The women were categorised into a control group (41 cases) and a DASH group (44 cases). Participants were followed until delivery. The clinical outcomes of mothers included gestational weeks of birth, deliverymode, postpartum haemorrhage and GH, as well as the incidenceof pre-eclampsia during the second and third trimesters. Newborn measurements were collected by evaluating prematurity, birth weight, body length and neonatal Apgar score. The incidence of pre-eclampsia, prematurity and low birth weight in the DASH group was lower than that in the control group (P<0.05). Significant differences were also observed in gestational age at delivery and the newborn body length between the two groups (P<0.05). We failed to find a significant difference in changes of deliverymode, postpartum haemorrhage, postpartum GH, mean birth weight and Apgar score (P>0.05) between the two diets. A DASH diet might comprise a potential strategy for improving the clinical outcomes in pregnant women with GH and chronic hypertension. Future robust clinical trials are warranted to corroborate these findings.